MBX Biosciences (MBX) Other Working Capital Changes (2023 - 2026)

MBX Biosciences has reported Other Working Capital Changes for 4 years, with the latest figure at -$41000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 2.38% year-over-year to -$41000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $601000.0 (up 480.38% YoY) and the FY2025 annual result came in at $600000.0, up 492.16% from the prior year.
• Other Working Capital Changes fell to -$41000.0 in Q1 2026 per MBX's latest filing, from $148000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.5 million in Q3 2025 and troughed at -$853000.0 in Q2 2025.
• A 4-year average of $411666.7 and a median of $569000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slipped 14.29% in 2024, then surged 1471.05% in 2025.
• Over 4 years, Other Working Capital Changes stood at -$35000.0 in 2023, then decreased by 14.29% to -$40000.0 in 2024, then jumped by 470.0% to $148000.0 in 2025, then plunged by 127.7% to -$41000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$41000.0, $148000.0, and -$27000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.